ClinicalTrials.govpublic full text
Effect of Henagliflozein on Hepatic Fat Content in Patients With T2DM and NAFLD
type2 diabetes mellitus, nonalcoholic fatty liver disease
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 267991
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.